Retatrutide is a newly developed therapy that acts as a potent GLP-1 receptor stimulator. This innovative treatment holds significant promise for controlling type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide improves insulin secretion and reduces glucagon release, leading to improved blood sugar control. Clinical trials have